With increasing specialty drug costs, pharmacy benefit managers,health plans and industry experts often tout the use of biosimilarsas a strategy to lower cost. In 2013,
Specialty Drug Manufacturer Assistance Programs And Your Plan by Sarah Martin, ASA, MAAA, FCA, CEBS, Vice President Manufacturer assistance, also known as patient assistance programs, copay